Market Newsdesk

GOSS Investors with Losses Encouraged to Contact the Firm Before June 1st Deadline

SAN FRANCISCO, May 23, 2026 /PRNewswire/ — A securities class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and an executive, seeking to represent investors who purchased or otherwise acquired Gossamer securities between June 16, 2025 and February 20, 2026.

The lawsuit follows Gossamer’s bombshell announcement on February 23, 2026 that top-line results for its Phase 3 PROSERA study did not meet the primary endpoint (the change from baseline in six-minute-walk distance at week 24). The study evaluated seralutinib for the treatment of pulmonary arterial hypertension (“PAH”).

The developments, including the trial failure and 80% stock drop, prompted national shareholder rights firm Hagens Berman to commence an investigation into the alleged pending claims that Gossamer violated federal securities laws.  The firm encourages Gossamer investors who suffered substantial losses on Class Period GOSS investments to submit your losses now.

The firm also encourages persons with knowledge who may be able to assist the investigation to contact its attorneys.

View our latest video summary of the allegations: youtu.be/TOr_OsDdBXY

Class Period: June 16, 2025 – Feb. 20, 2026
Lead Plaintiff Deadline: June 1, 2026
Visit:www.hbsslaw.com/investor-fraud/goss
Contact the Firm Now: [email protected]
                                         844-916-0895

Gossamer Bio, Inc. (GOSS) Securities Class Action:

The litigation is focused on the propriety of Gossamer’s disclosures about the Phase 3 PROSERA trial design, including its patient recruitment protocol and site-level monitoring.

In the past, Gossamer has emphasized that serlutinib is a “potential first-in-class therapeutic[,]” which “represents the possibility of a multi-billion-dollar opportunity across multiple indications[.]”

As recently as mid-November 2025, the company’s management cited the highly successful Merck Phase 3 STELLAR study of sotatercept for treating PAH. Gossamer’s management said, “if you look at their data, the best performing region was Latin America, and we have actually more patients coming from those same geographies and same sites.” Management also assured investors that “we have gone to the places where precedent studies have shown the greatest amount of efficacy, as well as having an entry criteria that is ensuring that we have patients who, we believe, will really show an improvement based upon, again background disease at week 24.”

The complaint alleges that, unknown to investors, Gossamer knew of or recklessly disregarded the trial design issues with the Phase 3 PROSERA study and, instead, crafted a narrative assuring investors that it would meet its primary endpoint. Also unknown to investors, patients at the study’s Latin America sites were largely heavily-treated and performing particularly well on placebo.

Investors’ expectations were dashed on February 23, 2026. That day, Gossamer announced that PROSERA did not meet its primary endpoint and therefore efficacy was not statistically significant.

Management said during the conference call that day, “[t]he overall treatment effect and statistical parameters were materially diluted by an outsize placebo response and meaningful regional heterogeneity, which compressed the pool placebo-adjusted difference.” More specifically, management revealed that in “Latin America, outsized placebo improvements materially compressed the pool treatment difference.”

The market swiftly reacted, sending the price of Gossamer shares down by 80%.

After the Class Period, on April 9, 2026, the company revealed that since February 24, 2026 it has not met the minimum share bid price ($1) required for continued listing on the Nasdaq Global Select Market.

“We’re focused on whether Gossamer may have misled investors about the PROSERA trial design, including patient entry criteria, as alleged in the pending lawsuit,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in Gossamer Bio and have substantial losses, or have knowledge that will assist the firm’s investigation, submit your losses now.

If you’d like more information and answers to additional frequently asked questions about the Gossamer case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding Gossamer Bio should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/gossamer-bio-inc-goss-faces-securities-class-action-amid-80-drop-on-phase-3-prosera-trial-failure-hbss-302780588.html

SOURCE Hagens Berman Sobol Shapiro LLP

IBRX Investors with Losses Encouraged to Contact the Firm Before
May 26th Deadline

SAN FRANCISCO, May 23, 2026 /PRNewswire/ — ImmunityBio, Inc. (NASDAQ: IBRX) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio securities between January 19, 2026 and March 24, 2026.

The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by its executive chairman and Chief Scientific and Medical Officer (Dr. Patrick Soon-Shiong) regarding ImmunityBio’s lead biologic product (Anktiva), which the FDA said were misleading efficacy claims.

This news drove the price of ImmunityBio shares down over 21% on March 24, 2026.

The developments have prompted national shareholders rights firm Hagens Berman to investigate claims that ImmunityBio violated the federal securities laws.

The firm urges investors in ImmunityBio who suffered significant losses to submit your losses now. The firm also encourages witnesses who may be able to assist in the investigation to contact its attorneys.

DEEP DIVE ANALYSIS: Visit Hagens Berman’s dedicated IBRX case page: www.hbsslaw.com/cases/immunitybio, or view our latest video summary of the allegations: https://youtu.be/e1pGV9KiS8U

Class Period: Jan. 19, 2026 – Mar. 24, 2026
Lead Plaintiff Deadline: May 26, 2026
Visit:www.hbsslaw.com/investor-fraud/ibrx
Contact the Firm Now:[email protected]
                                         844-916-0895

ImmunityBio, Inc. (IBRX) Securities Class Action:

ImmunityBio is a biotechnology company focused on innovating, developing, and commercializing next-generation immunotherapies designed to activate the patient’s immune system and deliver durable protection against cancer and infectious diseases.

The company’s Anktiva is an FDA-approved immunotherapy used with Bacillus Calmette-Guérin (“BCG”) to treat non-muscle invasive bladder cancer (“NMIBC”).

The lawsuit is focused on the propriety of ImmunityBio’s claims about Anktiva’s efficacy for treating other forms of cancer.

On January 19, 2026, a direct-to-consumer podcast (“Is the FDA BLOCKING Life Saving Cancer Treatments?”) aired, featuring Soon-Shiong. During the podcast, he said in part that, while Anktiva is approved for bladder cancer, “it actually can treat all cancers.” Soon-Shiong made other questionable claims about Anktiva, which together were flagged by the FDA as misleading.

On March 24, 2026, the financial press reported that the FDA sent a warning letter to ImmunityBio over claims made in the podcast and a TV ad. The warning letter states the “FDA has determined that the TV ad and podcast are false or misleading.” The FDA explained, “the promotional materials create the misleading impression that Anktiva, a treatment for a certain type of bladder cancer, can cure and even prevent all cancer.”

In addition, the FDA warned that “the representations in the TV ad and podcast misleadingly suggest that Anktiva will allow all NMIBC patients treated with Anktiva to be cancer-free for the long term, when this has not been demonstrated” and “we are not aware of data that support the efficacy claims and representations that Anktiva can ‘cure’ cancer.”

The FDA also said ImmunityBio’s promotional materials were misleading because “they fail to provide material information regarding Anktiva’s full FDA-approved indication.”

Lastly, the FDA warned that ImmunityBio’s “consistent and pervasive misleading efficacy claims and representations presented across promotional materials on different platforms are especially concerning from a public health perspective, given they grossly misrepresent the benefits of Anktiva.”

This news drove the price of ImmunityBio shares down over 21% on March 24, 2026, erasing nearly $2 billion of the company’s market capitalization.

“We’re investigating claims that ImmunityBio intentionally misled investors about Anktiva efficacy and indications,” said Reed Kathrein, the Hagens Berman partner leading the firm’s investigation.

If you invested in ImmunityBio and have substantial losses, or have knowledge that may assist the firm’s investigation, submit your losses now »

If you’d like more information and answers to frequently asked questions about the ImmunityBio case and the firm’s investigation, read more »

Whistleblowers: Persons with non-public information regarding ImmunityBio should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email [email protected].

About Hagens Berman

Hagens Berman is a global plaintiffs’ rights complex litigation firm focusing on corporate accountability. The firm is home to a robust practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and other wrongdoings. Hagens Berman’s team has secured more than $2.9 billion in this area of law. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/immunitybio-ibrx-facing-lawsuit-after-fda-flags-misleading-cancer-claims-shares-plunge-21-2b-market-cap-lost—-hbss-302780587.html

SOURCE Hagens Berman Sobol Shapiro LLP

NEW YORK, May 23, 2026 /PRNewswire/ —

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of FS KKR Capital Corp. (NYSE: FSK) between May 8, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important July 6, 2026 lead plaintiff deadline.

So what: If you purchased FS KKR Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the FS KKR Capital class action, go to https://rosenlegal.com/submit-form/?case_id=64089 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 6, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) FS KKR Capital overstated the effectiveness of its portfolio restructuring efforts for its nonaccrual companies; (2) FS KKR Capital overstated the valuation of its portfolio investments and/or overstated the effectiveness of FS KKR Capital’s portfolio valuation process; (3) FS KKR Capital overstated the durability of its quarterly distribution strategy; and (4) as a result of the foregoing, defendants’ positive statements about FS KKR Capital’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the FS KKR Capital class action, go to https://rosenlegal.com/submit-form/?case_id=64089 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.
     Phillip Kim, Esq.
     The Rosen Law Firm, P.A.
     275 Madison Avenue, 40th Floor
     New York, NY 10016
     Tel: (212) 686-1060
     Toll Free: (866) 767-3653
     Fax: (212) 202-3827
     [email protected]
     www.rosenlegal.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/fsk-investors-have-opportunity-to-lead-fs-kkr-capital-corp-securities-fraud-lawsuit-302780368.html

SOURCE THE ROSEN LAW FIRM, P. A.

IRVINE, Calif., May 23, 2026 /PRNewswire/ — As the global electric vehicle market enters a more competitive and demanding phase, automakers are increasingly realizing that success is no longer defined solely by product specifications or pricing. In today’s EV landscape, customer confidence, long-term ownership experience, and after-sales support are becoming decisive factors that separate sustainable brands from short-lived challengers.

Against that backdrop, VinFast is pursuing a distinctive global strategy, positioning after-sales service as a core competitive advantage.

That strategy was reinforced recently as VinFast signed new Memorandums of Understanding (MOUs) with 29 after-sales partners across international markets during a global partner event that brought together more than 200 investors, distributors, dealers, and service partners from North America, Europe, the Middle East, India, Indonesia, the Philippines, and Kazakhstan. The event marked a major milestone in VinFast’s efforts to rapidly scale its global service infrastructure and strengthen customer support capabilities worldwide.

After-sales as the foundation of global expansion

VinFast plans to expand its global service network to more than 1,100 workshops worldwide in 2026, spanning North America, Europe, the Middle East, and Asia. The network will operate under multiple models, including dealership service centers, fleet-support facilities, and third-party authorized repair partners in local markets.

In the United States, VinFast is expanding its after-sales capabilities through authorized service partnerships such as RepairWise, a digital-first automotive service platform that connects customers with certified repair facilities through remote diagnostics, online repair estimates, and streamlined appointment scheduling. The partnership is designed to complement and extend existing dealer service capabilities by helping improve service accessibility, reduce appointment wait times, and expand coverage in areas where dealership infrastructure is still growing.

In the EV industry, where concerns around battery health, maintenance costs, charging accessibility, and software reliability remain top priorities for consumers, a strong after-sales ecosystem is increasingly viewed as essential infrastructure. This is particularly true in the United States, one of the world’s most competitive and service-sensitive automotive markets.

For VinFast’s American partners, the company’s commitment to after-sales support is one of the primary reasons they believe the brand has long-term potential in the U.S.

‘What impressed us most was the ecosystem’

David Pributsky, Chief Commercial Officer and co-founder of Repairwise North America, said one of the most striking aspects of VinFast is not just the company itself, but the scale and integration of the broader Vingroup ecosystem supporting it.

According to Pributsky, what distinguishes VinFast from many emerging automakers is the fact that it is backed by a comprehensive ecosystem with interconnected capabilities across multiple sectors. “I’ve never worked directly with a company that has so many interconnected components within one ecosystem,” he said. “That’s something completely new to me.”

Anthony Rodio, CEO and co-founder of Repairwise, emphasized that visiting Vietnam and seeing the broader Vingroup ecosystem firsthand gave international partners greater confidence in VinFast’s long-term aspirations.

“One of the biggest surprises for me was having the opportunity to see the full breadth of the Vingroup ecosystem, from VinUniversity to the group’s many subsidiaries,” Rodio said. “It demonstrates a genuine commitment by VinFast and Vingroup to Vietnam, to its people, and to industries that are creating jobs, supporting communities, and driving economic growth.”

Why the after-sales strategy matters in America

The U.S. EV market is entering a transitional period. While consumer interest in electric vehicles remains strong, several legacy automakers have recently slowed or adjusted their EV expansion plans amid profitability concerns and changing market conditions.

For VinFast’s partners, that shift creates opportunity.

Pributsky believes there is a meaningful gap in the American market for well-equipped EVs offered at accessible price points and supported by strong customer service infrastructure.

“I strongly believe EVs represent better technology for the future,” he said. “However, in the U.S. market today, there are still too many expensive EVs and not enough high-quality options at accessible price points.”

According to him, VinFast’s integrated approach makes the company particularly compelling. “The combination of charging infrastructure, after-sales support, and competitive pricing makes VinFast very compelling for the U.S. market,” Pributsky explained. “That’s one of the key reasons we’re excited to work with them and help grow their presence in our market.”

He also believes VinFast’s long-term commitment gives the company a realistic pathway toward growth despite the challenges of entering a highly competitive market.

“The U.S. market is highly competitive and very different from Southeast Asia,” he acknowledged. “But I believe VinFast has an opportunity to gain traction.”

Importantly, he emphasized that VinFast’s willingness to invest heavily in service infrastructure is what gives partners confidence. “VinFast has demonstrated real commitment, and they have the people and resources to support their aspirations,” he said. “Expanding in the U.S. is not easy, but they are clearly committed to building for the long term.”

Rodio similarly believes after-sales coverage could become one of VinFast’s strongest advantages in the United States, especially given the country’s geographic scale.

“The U.S. is an enormous market,” Rodio said. “That creates a major opportunity for us to help provide service coverage for VinFast customers in areas where there may not yet be dealerships.”

“Our role is to help make the VinFast ownership experience easier and more convenient for customers across the United States,” Rodio said. “Through our digital service platform and independent repair network, we can help customers access qualified service locations more quickly, receive transparent repair estimates, and schedule repairs efficiently, whether they need warranty support or routine maintenance.”

He added that the partnership is designed to strengthen VinFast’s overall after-sales ecosystem while also supporting dealer operations as the brand continues expanding its retail footprint in the U.S. “As VinFast grows, having multiple authorized service pathways helps improve customer access, reduce delays, and create a more seamless ownership experience.”

VinFast’s expanded after-sales strategy is designed to work alongside its dealership network, with authorized third-party service partners helping extend service accessibility and customer support coverage in select markets. As the company continues growing its retail and dealership footprint in the United States, VinFast says the additional service infrastructure is intended to improve convenience and responsiveness for customers while supporting dealers with broader service capacity.

Confidence built through partnership

Beyond infrastructure and strategy, VinFast’s partners also point to the company’s collaborative mindset as a major reason they are committed to supporting its expansion.

Pributsky said Repairwise has worked closely with VinFast through a wide range of operational challenges and has been impressed by the company’s responsiveness and willingness to improve.

“VinFast has been an excellent partner for us,” he said. “They’ve provided strong support, and we’ve worked through many challenges together.”

More importantly, he emphasized that VinFast demonstrates a level of openness and adaptability that is critical for a fast-growing global company. “They listen carefully, they want to improve, and they’re always looking for ways to do better,” he said. “We also continue learning and improving on our side, but I’m deeply committed to this partnership and to what we’re building together in the United States.”

That spirit of long-term collaboration was reinforced throughout the global partner event, where many attendees highlighted the speed at which VinFast is evolving both technologically and operationally.

Following tours of VinFast’s manufacturing facilities, both executives expressed surprise at the level of automation and modernization inside the company’s production ecosystem.

“My first impression was how automated and advanced the factory was,” Rodio said. “Before visiting, I imagined a much more manual operation, but instead the facility was highly modern and technologically sophisticated.”

Together, those experiences reinforced a broader conclusion shared by many international partners. VinFast is not approaching global expansion as a short-term experiment. Instead, the company is investing in the long-term foundations necessary to compete internationally.

In an increasingly crowded EV market, VinFast’s belief that customer trust is earned through long-term service may ultimately become one of its most important differentiators. And for partners in the United States, that commitment is exactly why they believe the company deserves serious attention.

View original content to download multimedia:https://www.prnewswire.com/news-releases/built-for-the-long-term-why-us-partners-believe-in-vinfasts-global-service-strategy-302780603.html

SOURCE Vinfast Auto LLC

SINGAPORE, May 23, 2026 /PRNewswire/ — LightInTheBox Holding Co., Ltd. (NYSE: LITB) (“LightInTheBox” or the “Company”), a global consumer lifestyle company, today announced that the Company is providing an audio teleconference for participants who wish to virtually attend its extraordinary general meeting of shareholders (the “EGM”), scheduled to take place at 4 Pandan Crescent #03-03, Singapore, 128475, on May 25, 2026, beginning at 10:00 a.m. Singapore time. The teleconference dial-in details, the EGM agenda and the rules and procedures for the conduct of the EGM are set forth below.

Extraordinary General Meeting Teleconference Details

Date: Monday, May 25, 2026

Time: 10:00 a.m. Singapore Time

Dial-in Numbers:

United States:                    +1 646-254-3594
Singapore:                         +65 6818-5374
Mainland China:                 400-810-5222
Hong Kong, China:            +852 3005-1328
Passcode:                          046532038876

Agenda

Date: May 25, 2026
Time: 10 a.m. (Singapore Time)
Place: 4 Pandan Crescent #03-03, Singapore, 128475

I.        Call the Meeting to Order

A. Introduction
B. Instructions on Rules of Conduct and Procedures
C. Proof of Notice of Meeting
D. Proxies; Existence of Quorum

II.       Proposals

     Discussion of the Proposals

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Zhi Yan as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Jian He as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Zhiping Qi as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Zhentao Wang as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Xiongping Yu as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Meng Lian as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Ms. Ge Yan as a director of the Company until her term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Mr. Wei Yu as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Dr. Hanhua Wang as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Dr. Peng Wu as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT the re-election of Dr. Lei Deng as a director of the Company until his term of office due on March 31, 2028 is approved.

AS AN ORDINARY RESOLUTION THAT any one of the directors of the Company (the “Directors”, each a “Director”) to be authorised to take any and every action that might be necessary to effect the foregoing Proposals as such Director, in his or her absolute discretion, thinks fit.

III.      Voting

A. Opening of Polls
B. Voting on Proposals
C. Closing of Polls

IV.      Results of Voting

V.       Closure of Meeting

Rules and Procedures for the Conduct of Extraordinary General Meeting

We would like to welcome you to the extraordinary general meeting of shareholders of LightInTheBox Holding Co., Ltd. (the “Company”). In fairness to all shareholders in attendance and in the interest of an orderly meeting, we require that you honor the following rules of conduct:

1. All shareholders and proxy holders must register at the reception desk before entering the room for the meeting.
2. This meeting will be video recorded by the Company for purposes of maintaining an accurate record of the proceedings, including attendance, proxies, ballots, the poll and the voting results. Any other audio or video recording of the meeting is prohibited.
3. Because this is a meeting of our shareholders, you need to have the Company’s ordinary shares or the Company’s American depositary shares (“ADSs”) as of the close of business on the record date in order to vote. The ADSs holders were required to instruct The Bank of New York Mellon, the depositary of the Company’s ADS program (the “Depositary”) to vote on their behalf by completing and signing the Voting Card for ADSs holders. The ADSs holders are not eligible to vote during this extraordinary general meeting. If you have voted your shares or instructed the Depositary to vote on your behalf prior to the relevant dates set out in the voting instruction, your vote has been received by the Company and you are not eligible to vote those ADSs during the meeting. If you hold the Company’s ordinary shares directly (not through ADSs) and you wish to revoke or change your vote, you are able to do this during the meeting.
4. Attendance at this extraordinary general meeting will not, by itself, revoke a proxy.
5. We will strictly follow the Agenda as we conduct the meeting.
6. No questions will be taken during the meeting.
7. If there are any matters of individual concern to a shareholder and not of general concern to all shareholders, such matters may be raised separately after the meeting by contacting our Investor Relations Department.
8. In the event of any technical difficulty affecting the meeting generally, the meeting may be paused as necessary to address the issue. Individual technical difficulties will not delay or invalidate the meeting so long as quorum is present and the meeting can otherwise proceed in an orderly manner.

About LightInTheBox Holding Co., Ltd.

Founded in 2007, LightInTheBox is a global direct-to-consumer (DTC) e-commerce company dedicated to delivering a joyful lifestyle to consumers worldwide. Leveraging AI-driven market insights and agile supply chain systems, it aims to capture consumer preferences and sentiment to offer differentiated products, driving consumer engagement through deep emotional resonance. LightInTheBox also adopts a brand matrix strategy by launching its own apparel brands such as Ador to further strengthen its position as a consumer lifestyle company. Additionally, LightInTheBox offers a comprehensive suite of services to e-commerce companies, including advertising, supply chain management, payment processing, order fulfillment, and shipping and delivery solutions.

For more information, please visit https://ir.ador.com.

Safe Harbor Statement:

This press release contains forward-looking statements that involve risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “potential,” “continue,” “ongoing,” “targets” and similar statements. Among other things, statements that are not historical facts, including statements about LightInTheBox’s beliefs and expectations, the business outlook and quotations from management in this announcement, as well as LightInTheBox’s strategic and operational plans, are or contain forward-looking statements.

LightInTheBox may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the “SEC”), in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: LightInTheBox’s goals and strategies; LightInTheBox’s future business development, results of operations and financial condition; the expected growth of the global online retail market; LightInTheBox’s ability to attract customers and further enhance customer experience and product offerings; LightInTheBox’s ability to strengthen its supply chain efficiency and optimize its logistics network; LightInTheBox’s expectations regarding demand for and market acceptance of its products; competition; fluctuations in general economic and business conditions; changes in tariffs and trade policies; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in LightInTheBox’s filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and LightInTheBox does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

Investor Relations
LightInTheBox Holding Co., Ltd.
Email: [email protected]    

Serena Huang
Octans Capital Group
Email: [email protected]

View original content:https://www.prnewswire.com/news-releases/lightinthebox-to-hold-extraordinary-general-meeting-302780020.html

SOURCE LightInTheBox Holding Co., Ltd.

NEW YORK and NEW ORLEANS, May 22, 2026 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until June 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against SES AI Corporation (NYSE: SES) (“SES” or the “Company”), if they purchased or otherwise acquired the Company’s securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Massachusetts.

What You May Do

If you purchased securities of SES and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-ses/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by June 26, 2026.

>>>

CLICK HERE

for more information

About the Lawsuit

SES and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company overstated its business outlook by exaggerating the potential results of agreements with companies that had limited or no operational capacity; (ii) the company created the appearance of revenue by purchasing services tied to its own Molecular Universe transactions; (iii) despite its optimistic growth statements, SES AI faced significant logistics constraints in Q4 2025 that materially impacted revenue for that quarter; (iv) these issues raised serious doubts about SES AI’s 2026 growth prospects, which were later confirmed by weaker-than-expected revenue guidance for 2026; and (v) as a result, the Company’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

The case is Patel v. SES AI Corporation, et al., Case No. 26-cv-11894.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

View original content to download multimedia:https://www.prnewswire.com/news-releases/ses-ai-corporation-securities-fraud-class-action-result-of-weak-revenue-guidance-and-37-stock-decline—investors-may-contact-lewis-kahn-esq-at-kahn-swick–foti-llc-302780457.html

SOURCE Kahn Swick & Foti, LLC

NEW YORK and NEW ORLEANS, May 22, 2026 /PRNewswire/ — Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until July 17, 2026 to file lead plaintiff applications in a securities class action lawsuit against Sportradar Group AG (NasdaqGS: SRAD) (“Sportradar” or the “Company”), if they purchased or otherwise acquired the Company’s Class A ordinary shares between November 7, 2024 and April 21, 2026, inclusive (the “Class Period”).  This action is pending in the United States District Court for the Southern District of New York.

What You May Do

If you purchased shares of Sportradar as above and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-srad/?prs=prn to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by July 17, 2026.

>>>

CLICK HERE

for more information

About the Lawsuit

Sportradar and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. 

The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company intentionally worked with black-market gambling operators to increase its revenues, despite its assurances of strict legal and regulatory compliance and claims that ethics and integrity were crucial for Sportradar’s operations; (ii) the Company’s Know-Your-Customer (“KYC”) and compliance processes were not as robust as Defendants’ had claimed; and (iii) as a result, the Company’s statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

The case is Smale v. Sportradar Group AG, et al., Case No. 26-cv-4112.

>>>To Learn More, Click

HERE

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors – in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.

TOP 10 Plaintiff Law Firms – According to ISS Securities Class Action Services

To learn more about KSF, you may visit www.ksfcounsel.com.

>>>For More Information about the case, Click

HERE

Contact:

Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
[email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163

CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn

View original content to download multimedia:https://www.prnewswire.com/news-releases/sportradar-securities-fraud-class-action-result-of-compliance-misrepresentations-and-22-stock-decline—investors-may-contact-lewis-kahn-esq-at-kahn-swick–foti-llc-302780454.html

SOURCE Kahn Swick & Foti, LLC

SAN DIEGO, May 22, 2026 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, both dates inclusive (the “Class Period”), have until July 17, 2026 to seek appointment as lead plaintiff of the Commvault class action lawsuit.  Captioned Imbert v. Commvault Systems, Inc., No. 26-cv-05654 (D.N.J.), the Commvault class action lawsuit charges Commvault and certain of Commvault’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the

Commvault

class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-commvault-systems-inc-class-action-lawsuit-cvlt.html

You can also contact attorneys

Ken Dolitsky

or

Michael Albert

of Robbins Geller by calling 800/851-7783 or via e-mail at

[email protected]

.

CASE ALLEGATIONS: Commvault provides cyber resiliency solutions for enterprises to protect, secure, and recover data, applications, and identity systems.

The Commvault class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) defendants created the false impression that Commvault’s annualized recurring revenue (“ARR”) growth would remain steady throughout fiscal year 2026; (ii) Commvault knew or recklessly disregarded the impact that different types of sales would have on its ARR growth; and (iii) the variation in net ARR growth is strongly based on the type of sale Commvault is making, thus, Commvault’s projected net new ARR should not have been determined without properly factoring in sale type.

The Commvault class action lawsuit further alleges that on January 27, 2026, Commvault released its third quarter 2026 financial results, revealing net new ARR of $39 million, below Commvault’s previously guided $45 million.  On this news, the price of Commvault stock fell more than 31%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Commvault securities during the Class Period to seek appointment as lead plaintiff in the Commvault class action lawsuit.  A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.  A lead plaintiff acts on behalf of all other class members in directing the Commvault class action lawsuit.  The lead plaintiff can select a law firm of its choice to litigate the Commvault class action lawsuit.  An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Commvault class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation.  Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025.  This marks our fourth #1 ranking in the past five years.  And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm.  With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig.  Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 

Services may be performed by attorneys in any of our offices. 

Contact:

          Robbins Geller Rudman & Dowd LLP

          Ken Dolitsky

          Michael Albert

          655 W. Broadway, Suite 1900, San Diego, CA 92101

          800/851–7783

          [email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/cvlt-investor-deadline-commvault-systems-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-302779749.html

SOURCE Robbins Geller Rudman & Dowd LLP